Edward Walsh, MD
Radiation Oncology · Canton, OHNPI 1124010954
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,856 of the $10,195 with a category attached, or 96.7%. Sanofi Pasteur Inc. accounts for 96.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $9,979, more than ten times the $129 reported in 2019. Among radiation oncology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $637.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$10K
- Teleflex LLC$123
- Eisai Inc.$50
- E.r. Squibb & Sons, L.L.C.$36
- Lilly USA, LLC$26
- Astellas Pharma US Inc$26
- plus $79 from 4 others
What the payments were for
- Speaking & faculty fees$9,85697%
- Food & beverage$3233%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 1 | $9,856 |
| Teleflex LLC | 1 | $123 |
| Eisai Inc. | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $36 |
| Lilly USA, LLC | 2 | $26 |
| Astellas Pharma US Inc | 1 | $26 |
| Amgen | 2 | $25 |
| AstraZeneca | 2 | $24 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$123
How this compares
$10,195 in reported general payments places this provider in the 90th percentile of 255 radiation oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 24 | $496 |
| Ondansetron Hcl | 15 | $329 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $281 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $243 |
| Oxycodone Hcl | 12 | $159 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Canton
- Daniel SufficoolCanton$2K
- Steven KurtzmanGarfield Heights$833K
- Joshua PalmerColumbus$123K
- Norleena PoynterSandusky$90K
- Daniel SprattCleveland$86K
- Shlomo KoyfmanCleveland$72K
- Gerald SokolCleveland$61K
- Peter FriedFairfield$45K
- Rahul TendulkarCleveland$26K
- Sujith BaligaColumbus$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.